http://www.reportbuyer.com/rss.htmlBrowse the information you need on the Top 50 Pharma companies, specifics include Abbott Laboratories, Eisai, Merck and Sanofi-Aventis.en-gbReportbuyerservice@reportbuyer.comenquiries@redwiredesign.comhttp://www.reportbuyer.com/pharma_healthcare/company_reports_pharmaceutical/top_50_pharma/bayer.htmlBayer is a global enterprise, headquartered in Germany, with core competencies in the fields of healthcare, nutrition and high-tech materials, and organised into three subgroups, namely HealthCare, CropScience and MaterialScience. Following Bayer's acquisition of Schering AG on 23rd June 2006, Schering was renamed Bayer Schering Pharma and its integration into the Pharmaceuticals division of Bayer HealthCare is now under way. Bayer Schering Pharma is expected to contribute to over half the revenues of Bayer HealthCare. c8442df08fcece6148c5f51a9d1e1c1fSat, 31 Oct 2009 12:00:00 GBCompany Reports (Pharmaceutical)/Top 50 Pharmahttp://www.reportbuyer.com/pharma_healthcare/company_reports_pharmaceutical/top_50_pharma/boehringer_ingelheim_pipeline_products_performance_potential.htmlBoehringer Ingelheim has remained family-owned since its inception in 1885, and continues to be one of the world’s leading 20 pharmaceutical companies in terms of pharmaceutical revenue. The company’s activities now encompass 138 affiliates in 45 countries, employing 41,300 people. These activities are concentrated on two businesses, that of Human Pharmaceuticals and Animal Health. 712efc3ea3199c42cc3afb19e86a7757Wed, 30 Sep 2009 12:00:00 GBCompany Reports (Pharmaceutical)/Top 50 Pharmahttp://www.reportbuyer.com/pharma_healthcare/company_reports_pharmaceutical/top_50_pharma/bristol_myers_squibb_co_pharmavitae_profile.htmlThis analysis examines the historical and forecast performance for BMS in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative information. 8798bb390c89d18a2d2147779ee90f9fWed, 09 Sep 2009 12:00:00 GBCompany Reports (Pharmaceutical)/Top 50 Pharmahttp://www.reportbuyer.com/pharma_healthcare/company_reports_pharmaceutical/top_50_pharma/solvay_pipeline_products_performance_potential_1.htmlPharmaceutical company intelligence reports from Espicom provide a full review of the company's activities together with five-year sales forecasts for its key products. The company's financial performance is covered in-depth, from its latest results to a complete analysis of its latest full fiscal year and an outlook for the future. A section on company strategy covers mergers, acquisitions and divestitures, key agreements, products and R&D. 5ea0c26055012f15c76993ef09922434Wed, 09 Sep 2009 12:00:00 GBCompany Reports (Pharmaceutical)/Top 50 Pharmahttp://www.reportbuyer.com/pharma_healthcare/company_reports_pharmaceutical/top_50_pharma/astrazeneca_plc_pharmavitae_profile.htmlThis analysis examines the historical and forecast performance for AstraZeneca in the Rx pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative information. f1b34783a41fb9c8c2f9f4a6105b6c12Wed, 09 Sep 2009 12:00:00 GBCompany Reports (Pharmaceutical)/Top 50 Pharmahttp://www.reportbuyer.com/pharma_healthcare/company_reports_pharmaceutical/top_50_pharma/abbott_laboratories_pharmavitae_profile.htmlThis analysis examines the historical and forecast performance for Abbott in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative information. 2a6df73eb1746635d71ed7eae81f8218Wed, 09 Sep 2009 12:00:00 GBCompany Reports (Pharmaceutical)/Top 50 Pharmahttp://www.reportbuyer.com/pharma_healthcare/company_reports_pharmaceutical/top_50_pharma/novartis_1.htmlA strategic assessment of Novartis, one of the world's leading pharmaceutical companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals and strategies in the global pharmaceutical market. . ca3c968332deb9043a96ef1934ab2c11Tue, 01 Sep 2009 12:00:00 GBCompany Reports (Pharmaceutical)/Top 50 Pharmahttp://www.reportbuyer.com/pharma_healthcare/company_reports_pharmaceutical/top_50_pharma/sanofi_aventis.htmlA strategic assessment of Sanofi-Aventis, one of the world's leading pharmaceutical companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals and strategies in the global pharmaceutical market. . 619bf195cdaede5f54acb71bfc736834Tue, 01 Sep 2009 12:00:00 GBCompany Reports (Pharmaceutical)/Top 50 Pharmahttp://www.reportbuyer.com/pharma_healthcare/company_reports_pharmaceutical/top_50_pharma/johnson_johnson.htmlA strategic assessment of Johnson & Johnson, one of the world's leading pharmaceutical companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals and strategies in the global pharmaceutical market. . 72a5bf0cd3918798d460b5a818e9458bTue, 01 Sep 2009 12:00:00 GBCompany Reports (Pharmaceutical)/Top 50 Pharmahttp://www.reportbuyer.com/pharma_healthcare/company_reports_pharmaceutical/top_50_pharma/roche_1.htmlA strategic assessment of Roche, one of the world's leading pharmaceutical companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals and strategies in the global pharmaceutical market. . d5e9e1483980b0404468290e2c98fce8Tue, 01 Sep 2009 12:00:00 GBCompany Reports (Pharmaceutical)/Top 50 Pharmahttp://www.reportbuyer.com/pharma_healthcare/company_reports_pharmaceutical/top_50_pharma/wyeth.htmlA strategic assessment of Wyeth, one of the world's leading pharmaceutical companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals and strategies in the global pharmaceutical market. ec10d494d397477319a0aaca7b953eecTue, 01 Sep 2009 12:00:00 GBCompany Reports (Pharmaceutical)/Top 50 Pharmahttp://www.reportbuyer.com/pharma_healthcare/company_reports_pharmaceutical/top_50_pharma/pfizer.htmlA strategic assessment of Pfizer, one of the world's leading pharmaceutical companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals and strategies in the global pharmaceutical market. . 023d857f0c8cb3aebe015ad774e459b5Tue, 01 Sep 2009 12:00:00 GBCompany Reports (Pharmaceutical)/Top 50 Pharmahttp://www.reportbuyer.com/pharma_healthcare/company_reports_pharmaceutical/top_50_pharma/merck.htmlA strategic assessment of Merck, one of the world's leading pharmaceutical companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals and strategies in the global pharmaceutical market. . 8ac4e4fb9909c7599578ab7f05cdeb99Tue, 01 Sep 2009 12:00:00 GBCompany Reports (Pharmaceutical)/Top 50 Pharmahttp://www.reportbuyer.com/pharma_healthcare/company_reports_pharmaceutical/top_50_pharma/glaxosmithkline.htmlA strategic assessment of GlaxoSmithKline, one of the world's leading pharmaceutical companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals and strategies in the global pharmaceutical market. . 1581c161285411763548267403c2452eTue, 01 Sep 2009 12:00:00 GBCompany Reports (Pharmaceutical)/Top 50 Pharmahttp://www.reportbuyer.com/pharma_healthcare/company_reports_pharmaceutical/top_50_pharma/astrazeneca.htmlA strategic assessment of AstraZeneca, one of the world's leading pharmaceutical companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals and strategies in the global pharmaceutical market. . c083a14268e91c798ce9a6e78da8f4cdTue, 01 Sep 2009 12:00:00 GBCompany Reports (Pharmaceutical)/Top 50 Pharmahttp://www.reportbuyer.com/pharma_healthcare/company_reports_pharmaceutical/top_50_pharma/bristol_myers_squibb.htmlA strategic assessment of Bristol-Myers Squibb, one of the world's leading pharmaceutical companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals and strategies in the global pharmaceutical market. . 3ce8f2dc29aa1ec3d4ee30ba81b80270Tue, 01 Sep 2009 12:00:00 GBCompany Reports (Pharmaceutical)/Top 50 Pharmahttp://www.reportbuyer.com/pharma_healthcare/company_reports_pharmaceutical/top_50_pharma/abbott_laboratories_pipeline_products_performance_potential.html Pharmaceutical company intelligence reports from Espicom provide a full review of the company's activities together with five-year sales forecasts for its key products. The company's financial performance is covered in-depth, from its latest results to a complete analysis of its latest full fiscal year and an outlook for the future. A section on company strategy covers mergers, acquisitions and divestitures, key agreements, products and R&D. 0ad9425289636d31f109eedb8b43fef1Sat, 08 Aug 2009 12:00:00 GBCompany Reports (Pharmaceutical)/Top 50 Pharmahttp://www.reportbuyer.com/pharma_healthcare/company_reports_pharmaceutical/top_50_pharma/bms_medarex_valuable_partnership.htmlA positive move, but not one which deals with Bristol-Myers Squibb's upcoming patent expiry problems On July 22, 2009, Bristol-Myers Squibb announced that it would acquire - at a considerable premium - biopharmaceutical company Medarex for US$2. 4 billion. The deal secures rights for Bristol-Myers Squibb to the anti-cancer monoclonal antibody product ipilimumab, plus related revenues from Medarex' licensing deals and portfolio. 6d02a4a7e1c08f31d72673ac4913d409Sat, 08 Aug 2009 12:00:00 GBCompany Reports (Pharmaceutical)/Top 50 Pharmahttp://www.reportbuyer.com/pharma_healthcare/company_reports_pharmaceutical/top_50_pharma/roche_genentech_model_future_biotech_deals.htmlCould this single deal mark a phase of big pharma/biotech consolidation? In March 2009, after months of negotiations, Roche acquired the 44 percent of shares that it did not already own in its long-term biotech partner Genentech for US$46. 8 billion. The two companies are one of the most successful partnerships in the pharmaceutical industry. 44b8ad22a796691b77c3710a54e65f49Sat, 08 Aug 2009 12:00:00 GBCompany Reports (Pharmaceutical)/Top 50 Pharmahttp://www.reportbuyer.com/pharma_healthcare/company_reports_pharmaceutical/top_50_pharma/merck_co_schering_plough_marriage_convenience.htmlThe prospects for a major new company The pharmaceutical industry's appetite for major mergers seems unabated, and the $41. 1 billion Merck & Co/Schering-Plough deal - one of the largest ever mergers in the industry - has been confirmed just a few weeks after Pfizer announced that it would acquire Wyeth. Several observers have questioned both the timing and the value of the deal, arguing that, for example, the unresolved issue surrounding the potential loss of marketing rights to Remicade and Simponi make a proper valuation of Schering-Plough impossible. 91d9a894f78d8a8e211ae402a7a282adSat, 08 Aug 2009 12:00:00 GBCompany Reports (Pharmaceutical)/Top 50 Pharma